Improving time to optimal Staphylococcus aureus treatment using a penicillin-binding protein 2a assay.
Improving time to optimal Staphylococcus aureus treatment using a penicillin-binding protein 2a assay.
J Med Microbiol. 2016 Oct 14;:
Authors: Rao SN, Wang SK, Gonzalez Zamora J, Hanson AP, Polisetty RS, Singh K
Abstract
The penicillin-binding protein 2a (PBP2a) assay is a quick, accurate and inexpensive test for determining methicillin susceptibility in Staphylococcus aureus. A pre-post study design was conducted using a PBP2a assay with and without the impact of an antimicrobial stewardship (AS) intervention to improve time to optimal therapy for methicillin-susceptible (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) isolates. Our results demonstrate significantly improved time to optimal therapy and support the use of a PBP2a assay as part of an AS program for all healthcare facilities, especially those with limited resources.
PMID: 27902375 [PubMed - as supplied by publisher]
Source: Journal of Medical Microbiology - Category: Microbiology Authors: Rao SN, Wang SK, Gonzalez Zamora J, Hanson AP, Polisetty RS, Singh K Tags: J Med Microbiol Source Type: research
More News: Infectious Diseases | Microbiology | MRSA | Penicillin | Staphylococcus Aureus | Study | Superbugs